<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34614172</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1876-4479</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>10</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of Crohn's &amp; colitis</Title>
          <ISOAbbreviation>J Crohns Colitis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement.</ArticleTitle>
        <Pagination>
          <StartPage>554</StartPage>
          <EndPage>580</EndPage>
          <MedlinePgn>554-580</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ecco-jcc/jjab173</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">No consensus exists on defining intestinal ultrasound response, transmural healing, or transmural remission in inflammatory bowel disease, nor clear guidance for optimal timing of assessment during treatment. This systematic review and expert consensus study aimed to define such recommendations, along with key parameters included in response reporting.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Electronic databases were searched from inception to July 26, 2021, using pre-defined terms. Studies were eligible if at least two intestinal ultrasound [IUS] assessments at different time points during treatment were reported, along with an appropriate reference standard. The QUADAS-2 tool was used to examine study-level risk of bias. An international panel of experts [n = 18] rated an initial 196 statements [RAND/UCLA process, scale 1-9]. Two videoconferences were conducted, resulting in additional ratings of 149 and 13 statements, respectively.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 5826 records, 31 full-text articles, 16 abstracts, and one research letter were included; 83% [40/48] of included studies showed a low concern of applicability, and 96% [46/48] had a high risk of bias. A consensus was reached on 41 statements, with clear definitions of IUS treatment response, transmural healing, transmural remission, timing of assessment, and general considerations when using intestinal ultrasound in inflammatory bowel disease.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Response criteria and time points of response assessment varied between studies, complicating direct comparison of parameter changes and their relation to treatment outcomes. To ensure a unified approach in routine care and clinical trials, we provide recommendations and definitions for key parameters for intestinal ultrasound response, to incorporate into future prospective studies.</AbstractText>
          <CopyrightInformation>© The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ilvemark</LastName>
            <ForeName>Johan F K F</ForeName>
            <Initials>JFKF</Initials>
            <Identifier Source="ORCID">0000-0002-7792-9008</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hansen</LastName>
            <ForeName>Tawnya</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Section Gastroenterology, University of Manitoba, Manitoba, MN, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goodsall</LastName>
            <ForeName>Thomas M</ForeName>
            <Initials>TM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, John Hunter Hospital, Newcastle, NSW, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Health Sciences, School of Medicine, University of Adelaide, Adelaide, SA, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seidelin</LastName>
            <ForeName>Jakob B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al-Farhan</LastName>
            <ForeName>Heba</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Department of Internal Medicine, Al Amiri Hospital, Kuwait City, Kuwait.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Allocca</LastName>
            <ForeName>Mariangela</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Begun</LastName>
            <ForeName>Jakob</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0001-5256-7672</Identifier>
            <AffiliationInfo>
              <Affiliation>Mater Research Institute, University of Queensland, Brisbane, QLD, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bryant</LastName>
            <ForeName>Robert V</ForeName>
            <Initials>RV</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Queen Elizabeth Hospital, Adelaide, SA, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carter</LastName>
            <ForeName>Dan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Christensen</LastName>
            <ForeName>Britt</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0002-8746-4275</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, TRoyal Melbourne Hospital, Melbourne, VIC, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dubinsky</LastName>
            <ForeName>Marla C</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Susan and Leonard Feinstein IBD Clinical Center, Icahn School of Medicine, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gecse</LastName>
            <ForeName>Krisztina B</ForeName>
            <Initials>KB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kucharzik</LastName>
            <ForeName>Torsten</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, University Teaching Hospital Lüneburg, Lüneburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Cathy</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine. University of Calgary, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maaser</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Outpatients Department of Gastroenterology, University Teaching Hospital Lüneburg, Lüneburg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maconi</LastName>
            <ForeName>Giovanni</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology Unit, Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nylund</LastName>
            <ForeName>Kim</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Palmela</LastName>
            <ForeName>Carolina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology, Surgical Department, Hospital Beatriz Angelo, Loures, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wilson</LastName>
            <ForeName>Stephanie R</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Novak</LastName>
            <ForeName>Kerri</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine. University of Calgary, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wilkens</LastName>
            <ForeName>Rune</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-4928-4708</Identifier>
            <AffiliationInfo>
              <Affiliation>Gastrounit, Division of Medicine, Hvidovre University Hospital, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Copenhagen Centre for Inflammatory Bowel Disease in Children, Adolescents and Adults, University of Copenhagen, Hvidovre Hospital, Copenhagen, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Crohns Colitis</MedlineTA>
        <NlmUniqueID>101318676</NlmUniqueID>
        <ISSNLinking>1873-9946</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>J Crohns Colitis. 2021 Dec 18;:</RefSource>
          <PMID Version="1">34922384</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015212" MajorTopicYN="Y">Inflammatory Bowel Diseases</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007422" MajorTopicYN="N">Intestines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Intestinal ultrasound</Keyword>
        <Keyword MajorTopicYN="N">inflammatory bowel disease</Keyword>
        <Keyword MajorTopicYN="N">transmural healing</Keyword>
        <Keyword MajorTopicYN="N">transmural remission</Keyword>
        <Keyword MajorTopicYN="N">treatment response</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>6</Day>
          <Hour>17</Hour>
          <Minute>32</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34614172</ArticleId>
        <ArticleId IdType="pmc">PMC9089416</ArticleId>
        <ArticleId IdType="doi">10.1093/ecco-jcc/jjab173</ArticleId>
        <ArticleId IdType="pii">6382324</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>

Maaser
 C, Sturm A, Vavricka SR, et al. ; European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD. Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 2019;13:144–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30137275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Bryant
 RV, Friedman AB, Wright EK, et al. 
 Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. Gut 2018;67:973–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29437914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Rajagopalan
 A, Sathananthan D, An YK, et al. 
 Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease-related knowledge. JGH Open 2020;4:267–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7144798</ArticleId>
            <ArticleId IdType="pubmed">32280776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Smith
 RL, Taylor KM, Friedman AB, Gibson RN, Gibson PR. Systematic review: clinical utility of gastrointestinal ultrasound in the diagnosis, assessment, and management of patients with ulcerative colitis. J Crohns Colitis 2020;14:465–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31562739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Dong
 J, Wang H, Zhao J, et al. 
 Ultrasound as a diagnostic tool in detecting active Crohn’s disease: a meta-analysis of prospective studies. Eur Radiol 2014;24:26–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23921767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Maconi
 G, Nylund K, Ripolles T, et al. 
 EFSUMB Recommendations and Clinical Guidelines for Intestinal Ultrasound [GIUS] in Inflammatory Bowel Diseases. Ultraschall Med 2018;39:304–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29566419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Goodsall
 TM, Nguyen TM, Parker CE, et al. 
 Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease. J Crohns Colitis 2021;15:609–14.</Citation>
        </Reference>
        <Reference>
          <Citation>

Wilkens
 R, Novak KL, Maaser C, Panaccione R, Kucharzik T. Relevance of monitoring transmural disease activity in patients with Crohn’s disease: current status and future perspectives. Therap Adv Gastroenterol 2021;14:17562848211006672.</Citation>
        </Reference>
        <Reference>
          <Citation>

Turner
 D, Ricciuto A, Lewis A, et al. ; International Organization for the Study of IBD. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease [STRIDE] Initiative of the International Organization for the Study of IBD [IOIBD]: Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 2021;160:1570–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33359090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Fitch
 K, Aguilar S, Burnand M, LaCalle B.
 The RAND/UCLA Appropriateness Method User’s Manual. Santa Monica, CA: Rand; 2001.</Citation>
        </Reference>
        <Reference>
          <Citation>
Veritas Health Innovation. Covidence Systematic Review Software. 2019. www.covidence.org . Accessed April 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>

Bots
 S, Nylund K, Löwenberg M, Gecse K, Gilja OH, D’Haens G. Ultrasound for assessing disease activity in IBD patients: a systematic review of activity scores. J Crohns Colitis 2018;12:920–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29684200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Whiting
 PF, Rutjes AW, Westwood ME, et al. ; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22007046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Harris
 PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture [REDCap] – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2700030</ArticleId>
            <ArticleId IdType="pubmed">18929686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Harris
 PA, Taylor R, Minor BL, et al. ; REDCap Consortium. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 2019;95:103208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7254481</ArticleId>
            <ArticleId IdType="pubmed">31078660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Paredes
 JM, Moreno N, Latorre P, et al. 
 Clinical impact of sonographic transmural healing after anti-TNF antibody treatment in patients with Crohn’s disease. Dig Dis Sci 2019;64:2600–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30874986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Paredes
 JM, Ripollés T, Cortés X, et al. 
 Abdominal sonographic changes after antibody to tumor necrosis factor [anti-TNF] alpha therapy in Crohn’s Disease. Dig Dis Sci 2010;55:404–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19267199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Castiglione
 F, Testa A, Rea M, et al. 
 Transmural healing evaluated by bowel sonography in patients with Crohn’s disease on maintenance treatment with biologics. Inflamm Bowel Dis 2013;19:1928–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23835441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Castiglione
 F, Mainenti P, Testa A, et al. 
 Cross-sectional evaluation of transmural healing in patients with Crohn’s disease on maintenance treatment with anti-TNF alpha agents. Dig Liver Dis 2017;49:484–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28292640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kucharzik
 T, Wittig BM, Helwig U, et al. ; TRUST study group. Use of intestinal ultrasound to monitor Crohn’s disease activity. Clin Gastroenterol Hepatol 2017;15:535–42.e2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27856365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ripollés
 T, Paredes JM, Martínez-Pérez MJ, et al. 
 Ultrasonographic changes at 12 weeks of anti-TNF drugs predict 1-year sonographic response and clinical outcome in Crohn’s disease: a multicenter study. Inflamm Bowel Dis 2016;22:2465–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27580385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ripollés
 T, Martínez MJ, Barrachina MM. Crohn’s disease and color Doppler sonography: response to treatment and its relationship with long-term prognosis. J Clin Ultrasound 2008;36:267–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18067121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Dubbins
 PA. Ultrasound demonstration of bowel wall thickness in inflammatory bowel disease. Clin Radiol 1984;35:227–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6713799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Onali
 S, Calabrese E, Petruzziello C, et al. 
 Endoscopic vs ultrasonographic findings related to Crohn’s disease recurrence: a prospective longitudinal study at 3 years. J Crohns Colitis 2010;4:319–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21122521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Moreno
 N, Ripollés T, Paredes JM, et al. 
 Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn’s disease: changes following treatment with immunomodulators and/or anti-TNF antibodies. J Crohns Colitis 2014;8:1079–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24613399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Orlando
 S, Coletta M, Fraquelli M, et al. 
 Ultrasound elasticity imaging predicts therapeutic outcome in patients with crohn’s disease treated with anti-tumor necrosis factor antibodies. Dig Liver Dis 2017;49:e98.</Citation>
        </Reference>
        <Reference>
          <Citation>

Socaciu
 M, Ciobanu L, Diaconu B, Hagiu C, Seicean A, Badea R. Non-invasive assessment of inflammation and treatment response in patients with Crohn’s disease and ulcerative colitis using contrast-enhanced ultrasonography quantification. J Gastrointestin Liver Dis 2015;24:457–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26697572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Goertz
 RS, Klett D, Wildner D, Atreya R, Neurath MF, Strobel D. Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study. Acta Radiol 2018;59:1149–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29345146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Quaia
 E, Gennari AG, Cova MA. Early predictors of the long-term response to therapy in patients with Crohn disease derived from a time-intensity curve analysis after microbubble contrast agent injection. J Ultrasound Med 2019;38:947–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30208230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Saevik
 F, Nylund K, Hausken T, Ødegaard S, Gilja OH. Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn’s disease. Inflamm Bowel Dis 2014;20:2029–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4213134</ArticleId>
            <ArticleId IdType="pubmed">25185684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Chen
 JM, He LW, Yan T, et al. 
 Oral exclusive enteral nutrition induces mucosal and transmural healing in patients with Crohn’s disease. Gastroenterol Rep [Oxf] 2019;7:176–84.</Citation>
        </Reference>
        <Reference>
          <Citation>

Hoffmann
 P, Krisam J, Wehling C, et al. 
 Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease. World J Gastroenterol 2019;25:4481–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6710179</ArticleId>
            <ArticleId IdType="pubmed">31496626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Zorzi
 F, Ghosh S, Chiaramonte C, et al. 
 Response assessed by ultrasonography as target of biological treatment for Crohn’s Disease. Clin Gastroenterol Hepatol 2020;18:2030–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31866561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Calabrese
 E, Rispo A, Zorzi F, et al. 
 Ultrasonography tight control and monitoring in Crohn’s disease during different biological therapies: a multicenter study. Clin Gastroenterol Hepatol 2021. Doi: 10.1016/j.cgh.2021.03.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cgh.2021.03.030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Hoffmann
 T, Fusco S, Blumenstock G, Sadik S, Malek NP, Froehlich E. Evaluation of bowel wall thickness by ultrasound as early diagnostic tool for therapeutic response in Crohn’s disease patients treated with ustekinumab. Z Gastroenterol 2020. Doi: 10.1055/a-1283-6550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/a-1283-6550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ma
 L, Li W, Zhuang N, et al. 
 Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn’s disease. Therap Adv Gastroenterol 2021;14:17562848211016259.</Citation>
        </Reference>
        <Reference>
          <Citation>

Helwig
 U, Fischer I, Hammer L, et al. 
 Transmural response and transmural healing defined by intestinal ultrasound—new potential therapeutic targets?
 J Crohns Colitis 2022;16:57–67.</Citation>
        </Reference>
        <Reference>
          <Citation>

Jessen
 B, Rodriguez-Sillke Y, Sonnenberg E, et al. 
 Level of tumor necrosis factor production by stimulated blood mononuclear cells can be used to predict response of patients with inflammatory bowel diseases to infliximab. Clin Gastroenterol Hepatol 2021;19:721–31.e1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32272247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Parente
 F, Molteni M, Marino B, et al. 
 Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis?: a prospective study. Am J Gastroenterol 2010;105:1150–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19997096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Maaser
 C, Petersen F, Helwig U, et al. ; German IBD Study Group and the TRUSTandUC Study Group.. Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUSTandUC study. Gut 2020;69:1629–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7456734</ArticleId>
            <ArticleId IdType="pubmed">31862811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Maconi
 G, Ardizzone S, Parente F, Bianchi Porro G. Ultrasonography in the evaluation of extension, activity, and follow-up of ulcerative colitis. Scand J Gastroenterol 1999;34:1103–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10582761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Yoshida
 A, Kobayashi K, Ueno F, et al. 
 Possible role of early transabdominal ultrasound in patients undergoing cytapheresis for active ulcerative colitis. Intern Med 2011;50:11–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21212567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Hean
 R, Su H, Taylor K, et al. 
 The value of gastrointestinal ultrasound in predicting sonographic remission to vedolizumab: A step towards individualized biological therapy of inflammatory bowel disease [abstract]. J Gastroenterol Hepatol 2019;34: 157–8.</Citation>
        </Reference>
        <Reference>
          <Citation>

Maaser
 C, Petersen F, Helwig U, et al. 
 Monitoring response to anti-TNF therapy in ulcerative colitis patients by gastrointestinal ultrasound: sub-analysis from TRUSTandUC [abstract]. J Crohns Colitis 2019;13:S063–4.</Citation>
        </Reference>
        <Reference>
          <Citation>

Arienti
 V, Campieri M, Boriani L, et al. 
 Management of severe ulcerative colitis with the help of high resolution ultrasonography. Am J Gastroenterol 1996;91:2163–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8855741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

de Voogd
 F, Van Wassenaer E, Mookhoek A, et al. 
 Decrease in bowel wall thickness at intestinal ultrasound accurately detects early endoscopic remission and improvement in ulcerative colitis patients on tofacitinib: a longitudinal prospective cohort study [abstract]. J Crohns Colitis 2021;15:S315–7.</Citation>
        </Reference>
        <Reference>
          <Citation>

Kucharzik
 T, Helwig U, Seibold F, et al. 
 Improvement of intestinal ultrasound parameters within 12 weeks after treatment induction in CD and UC patients—first interim analysis of the trust beyond study [abstract]. United Eur Gastroenterol J 2020;8:356.</Citation>
        </Reference>
        <Reference>
          <Citation>

Maaser
 C, Helwig U, Fischer I, Rath S, Kolterer S, Kucharzik T. Patient-Reported Outcomes [PRO-2] and intestinal ultrasound in ulcerative colitis patients—subanalysis of the TRUSTandUC study cohort [abstract]. Gastroenterology 2020;158:694.</Citation>
        </Reference>
        <Reference>
          <Citation>

Nylund
 K, Maconi G, Hollerweger A, et al. 
 EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound. Ultraschall Med 2017;38:e1–e15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27604052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Nylund
 K, Hausken T, Ødegaard S, Eide GE, Gilja OH. Gastrointestinal wall thickness measured with transabdominal ultrasonography and its relationship to demographic factors in healthy subjects. Ultraschall Med 2012;33:E225–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22504939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Zink
 F, Kratzer W, Schmidt S, et al. 
 Comparison of two high-end ultrasound systems for contrast-enhanced ultrasound quantification of mural microvascularity in Crohn’s Disease. Ultraschall Med 2016;37:74–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26251995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Bouguen
 G, Levesque BG, Pola S, Evans E, Sandborn WJ. Endoscopic assessment and treating to target increase the likelihood of mucosal healing in patients with Crohn’s disease. Clin Gastroenterol Hepatol 2014;12:978–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24246770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Vasudevan
 A, Gibson PR, van Langenberg DR. Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told? World J Gastroenterol 2017;23:6385–402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5643264</ArticleId>
            <ArticleId IdType="pubmed">29085188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ordás
 I, Rimola J, Rodríguez S, et al. 
 Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease. Gastroenterology 2014;146:374–82.e1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24177375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Scarallo
 L, Maniscalco V, Paci M, et al. 
 Bowel ultrasound scan predicts corticosteroid failure in children with acute severe colitis. J Pediatr Gastroenterol Nutr 2020;71:46–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32102087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Dillman
 JR, Dehkordy SF, Smith EA, et al. 
 Defining the ultrasound longitudinal natural history of newly diagnosed pediatric small bowel Crohn disease treated with infliximab and infliximab-azathioprine combination therapy. Pediatr Radiol 2017;47:924–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5511547</ArticleId>
            <ArticleId IdType="pubmed">28421251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kucharzik
 T, Wilkens R, Maconi G, et al. 
 Intestinal ultrasound response and transmural healing after ustekinumab induction in Crohn’s disease: Week 16 interim analysis of the STARDUST trial substudy [abstract]. J Crohns Colitis 2020;14:S046–8.</Citation>
        </Reference>
        <Reference>
          <Citation>

Kucharzik
 T, Wilkens R, Maconi G, et al. 
 Intestinal ultrasound response and transmural healing after 48 weeks of treatment with ustekinumab in Crohn’s disease: STARDUST Trial sub-study [abstract]. United Eur Gastroenterol J 2020;8:1258–75.</Citation>
        </Reference>
        <Reference>
          <Citation>

Civitelli
 F, Nuti F, Oliva S, et al. 
 Looking beyond mucosal healing: effect of biologic therapy on transmural healing in pediatric Crohn’s Disease. Inflamm Bowel Dis 2016;22:2418–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27598739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Moreno Sánchez
 N, Paredes JM, Ripollés T, et al. 
 Treatment of abdominal fistulas in Crohn’s disease and monitoring with abdominal ultrasonography. Rev Esp Enferm Dig 2021;113:240–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33226252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Choi
 J, Phan B, Dubinsky M, Rosenberg H. Use of small bowel ultrasound to predict response to infliximab induction [abstract]. Pediatr Radiol 2018;48:S80.</Citation>
        </Reference>
        <Reference>
          <Citation>

Novak
 KL, Nylund K, Maaser C, et al. 
 Expert consensus on optimal acquisition and development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn’s Disease. J Crohns Colitis 2020;15: 609–16.</Citation>
        </Reference>
        <Reference>
          <Citation>

Novak
 KL, Kaplan GG, Panaccione R, et al. 
 A simple ultrasound score for the accurate detection of inflammatory activity in Crohn’s Disease. Inflamm Bowel Dis 2017;23:2001–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28644185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Sævik
 F, Eriksen R, Eide GE, Gilja OH, Nylund K. Development and validation of a simple ultrasound activity score for Crohn’s Disease. J Crohns Colitis 2021;15:115–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7805799</ArticleId>
            <ArticleId IdType="pubmed">32504533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kunihiro
 K, Hata J, Haruma K, Manabe N, Tanaka S, Chayama K. Sonographic detection of longitudinal ulcers in Crohn disease. Scand J Gastroenterol 2004;39:322–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15125463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ripollés
 T, Poza J, Suarez Ferrer C, Martínez-Pérez MJ, Martín-Algíbez A, de Las Heras Paez B. Evaluation of Crohn’s disease activity: development of an ultrasound score in a multicenter study. Inflamm Bowel Dis 2021;27:145–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32507880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Bots
 S, Nylund K, Löwenberg M, Gecse K, D’Haens G. Intestinal ultrasound to assess disease activity in ulcerative colitis: development of a novel UC-Ultrasound index. J Crohns Colitis 2021;15:877–8.</Citation>
        </Reference>
        <Reference>
          <Citation>

De Voogd
 F, Wilkens R, Gecse K, et al. 
 A reliability study: strong inter-observer agreement of an expert panel for intestinal ultrasound in ulcerative colitis. J Crohns Colitis 2021;15:1284–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8328294</ArticleId>
            <ArticleId IdType="pubmed">33420784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ordás
 I, Rimola J, Alfaro I, et al. 
 Development and validation of a simplified magnetic resonance index of activity for Crohn’s Disease. Gastroenterology 2019;157:432–9.e1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30953614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Liu
 C, Ding SS, Zhang K, et al. 
 Correlation between ultrasound consolidated score and simple endoscopic score for determining the activity of Crohn’s disease. Br J Radiol 2020;93:20190614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7217571</ArticleId>
            <ArticleId IdType="pubmed">32101466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Marin
 AM, Calapod OP, Moldoveanu AC, Tribus LC, Fierbințeanu-Braticevici C. Non-invasive ultrasonographic score for assessment of the severity of inflammatory bowel disease. Ultrasound Med Biol 2021;47:932–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33388210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ma
 H, Isaac DM, Petrova A, et al. 
 Validation of a modified simple ultrasound activity score for children with Crohn’s disease [abstract]. In: Proceedings of the 16th ECCO Congress; July 2-3 and 8-10 2021; virtual.</Citation>
        </Reference>
        <Reference>
          <Citation>

Van Wassenaer
 E, Benninga MA, Koot BGP, et al. 
 The development of the PCD-US: The Pediatric Crohn’s Disease intestinal Ultrasound Score. J Pediatr Gastroenterol Nutr 2021;72:90.</Citation>
        </Reference>
        <Reference>
          <Citation>

Allocca
 M, Filippi E, Costantino A, et al. 
 Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation. United European Gastroenterol J 2021;9:438–42.</Citation>
        </Reference>
        <Reference>
          <Citation>

Zhang
 M, Zhang H, Zhu Q, et al. 
 Bowel ultrasound enhances predictive value based on clinical indicators: a scoring system for moderate-to-severe endoscopic activities in patients with ulcerative colitis. Therap Adv Gastroenterol 2021;14:17562848211030050.</Citation>
        </Reference>
        <Reference>
          <Citation>

Halasz
 J, Lu C, Kaplan G, et al. 
 Early 12-week ultrasound response to treatment, used as a predictor of response at 6 months in Crohn’s disease: A prospective cohort study [abstract]. J Crohns Colitis 2018;12:S384.</Citation>
        </Reference>
        <Reference>
          <Citation>

Di Fluri
 G, Ceccarelli L, Ricchiuti A, et al. 
 Role of contrast-enhanced ultrasonography [CEUS] in assessment of inflammatory activity in patients with small bowel crohn’s disease [abstract]. Gastroenterology 2013;144:S423.</Citation>
        </Reference>
        <Reference>
          <Citation>

Wilkens
 R, Lu C, Novak KL, et al. 
 Which ultrasound change occurs most quickly in response to treatment in Crohn’s disease: Reduction in bowel wall thickness or mural perfusion? [abstract]. United Eur Gastroenterol J 2019;6:621–2.</Citation>
        </Reference>
        <Reference>
          <Citation>

Limberg
 B. [Diagnosis of chronic inflammatory bowel disease by ultrasonography]. Z Gastroenterol 1999;37:495–508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10427656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Yasuhara
 H, Kunisaki R, Tsunoda S, et al. 
 Early transabdominal ultrasonography to assess intestinal wall thickness and vascularity appears to predict long-term outcome in Crohn’s disease patients undergoing infliximab therapy: A prospective study [abstract]. J Crohns Colitis 2015;9:S19–20.</Citation>
        </Reference>
        <Reference>
          <Citation>

Fraquelli
 M, Branchi F, Cribiù FM, et al. 
 The role of ultrasound elasticity imaging in predicting ileal fibrosis in crohn’s disease patients. Inflamm Bowel Dis 2015;21:2605–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26230861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kucharzik
 T, Maaser C, Helwig U, et al. 
 Monitoring response to adalimumab therapy in Crohn’s disease patients by bowel ultrasound: sub-analysis from TRUST [abstract]. J Crohns Colitis 2018;12:S319.</Citation>
        </Reference>
        <Reference>
          <Citation>

Castiglione
 F, Imperatore N, Testa A, et al. 
 One-year clinical outcomes with biologics in Crohn’s disease: transmural healing compared with mucosal or no healing. Aliment Pharmacol Ther 2019;49:1026–39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30854708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Geyl
 S, Guillo L, Laurent V, D’Amico F, Danese S, Peyrin-Biroulet L. Transmural healing as a therapeutic goal in Crohn’s disease: a systematic review. Lancet Gastroenterol Hepatol 2021. Doi: 10.1016/S2468-1253[21]00096-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2468-1253[21]00096-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Goodsall
 TM, Jairath V, Feagan BG, et al. 
 Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease. Aliment Pharmacol Ther 2021;53:873–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33641221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Sagami
 S, Kobayashi T, Miyatani Y, et al. 
 Accuracy of ultrasound for evaluation of colorectal segments in patients with inflammatory bowel diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2021;19:908–21.e6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32777549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Gomes
 CF, Nascimento CN, Pereira F, et al. 
 Use of bowel ultrasound to assess disease activity in Crohn’s disease patients after induction therapy with infliximab [abstract]. J Crohn’s Colitis 2020;14:S431.</Citation>
        </Reference>
        <Reference>
          <Citation>

Civitelli
 F, Oliva S, Cersosimo K, et al. 
 Long-term impact of transmural healing on the clinical outcome of pediatric Crohn’s disease [abstract]. Dig Liver Dis 2017;49:e263.</Citation>
        </Reference>
        <Reference>
          <Citation>

Wilkens
 R, Hagemann-Madsen RH, Peters DA, et al. 
 Validity of contrast-enhanced ultrasonography and dynamic contrast-enhanced MR enterography in the assessment of transmural activity and fibrosis in Crohn’s disease. J Crohns Colitis 2018;12:48–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28981627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Maconi
 G, Greco S, Duca P, et al. 
 Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn’s disease. Inflamm Bowel Dis 2008;14:1555–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18521926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Smith
 RL, Taylor KM, Friedman AB, Swaine AP, Gibson DJ, Gibson PR. Early assessment with gastrointestinal ultrasound in patients hospitalised for a flare of ulcerative colitis and predicting the need for salvage therapy: a pilot study. Ultrasound Med Biol 2021;47:1108–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33413967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Haber
 HP, Busch A, Ziebach R, Stern M. Bowel wall thickness measured by ultrasound as a marker of Crohn’s disease activity in children [research letter]. Lancet 2000;355:1239–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10770308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Dolinger
 MT, Choi JJ, Phan BL, Rosenberg HK, Rowland J, Dubinsky MC. Use of small bowel ultrasound to predict response to infliximab induction in pediatric Crohn’s Disease. J Clin Gastroenterol 2021;55:429–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32453126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Peyrin-Biroulet
 L, Panés J, Sandborn WJ, et al. 
 Defining disease severity in inflammatory bowel diseases: current and future directions. Clin Gastroenterol Hepatol 2016;14:348–54.e17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26071941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Peyrin-Biroulet
 L, Reinisch W, Colombel JF, et al. 
 Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn’s disease in the SONIC trial. Gut 2014;63:88–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23974954</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
